摘要 |
<p>Compounds of formula (I) are inhibitors of PI3 kinase activity, and useful in treatment of, inter alia, autoimmune, inflammatory and proliferative diseases; wherein s is 0 or 1; U is hydrogen or halogen; X is -(C=O)-, or an optionally substituted divalent phenylene, pyridinylene, pyrimidinylene, or pyrazinylene radical, or a bond; P is optionally substituted C<SUB>1</SUB>-C<SUB>6</SUB> alkyl and Z is -(CH<SUB>2</SUB>)<SUB>Z</SUB>-Y<SUP>1</SUP>-L<SUP>1</SUP>-R or Z is optionally substituted C<SUB>1</SUB>-C<SUB>6</SUB> alkyl and P is -(CH<SUB>2</SUB>)<SUB>Z</SUB>-Y<SUP>1</SUP>-L<SUP>1</SUP>-R; and z, Y<SUP>1</SUP>, L<SUP>1 </SUP>and R are as defined in the claims.</p> |
申请人 |
CHROMA THERAPEUTICS LTD.;MOFFAT, DAVID, FESTUS, CHARLES;DAVIES, STEPHEN;ALESSO, SONIA, MARIA;LAUNAY, DELPHINE, FRANCOISE, MONIQUE |
发明人 |
MOFFAT, DAVID, FESTUS, CHARLES;DAVIES, STEPHEN;ALESSO, SONIA, MARIA;LAUNAY, DELPHINE, FRANCOISE, MONIQUE |